LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 3.3% of their position (26.86K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $93.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2026ACC: 0001995275-26-000006
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
+804.29K
Net shares
Net buyer
$93.5K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
1.61M acquired · 802.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+775.83K
Price / share
—
Trade value
—
% of position
1740.3%
4/1/2026
44.58K→820.41K
Common Stock
Direct
Shares
−26.86K
Price / share
$3.48
Trade value
$93.47K
% of position
3.3%
4/2/2026
820.41K→793.55K
Total
Net shares
+748.97K
Net value
-$93.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +775.83K | — | — | 1740.3% | 44.58K | 820.41K |
| Common Stock Direct | 4/2/2026 | S · Sale | −26.86K | $3.48 | $93.47K | 3.3% | 820.41K | 793.55K |
| Total | +748.97K | -$93.47K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
775.83K shares
Shares
−775.83K
Strike price
Held after
0.00
Exercisable
—
4/1/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
831.15K shares
Shares
+831.15K
Strike price
3.54
Held after
831.15K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock775.83K shares | 4/1/2026 | M · Option Exercise | −775.83K | — | 0.00 | |
| Stock Option (right to buy) Direct | Common Stock831.15K shares | 4/1/2026 | A · Award | +831.15K | 3.54 | — | 831.15K |